Aptinyx Inc. announced that on May 6, 2019, the Board unanimously appointed Henry O. Gosebruch to the Board. Upon his appointment to the Board, Mr. Gosebruch became a member of the class of directors with terms expiring at the 2021 Annual Meeting of Stockholders of the Company. On August 28, 2019, the Board appointed Mr. Gosebruch to serve as a member of the Compensation and Management Development Committee of the Board. Mr. Gosebruch, age 46, has served as executive vice president and chief strategy officer at AbbVie Inc.